Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data

Suboptimal use of hormonal therapy among German men with localized high-risk prostate Cancer during 2005 to 2015: analysis of registry data

Abstract Background This study assesses the use of hormonal therapy to treat high-risk localized prostate cancer (HRLPCa) cases diagnosed between 2005 and 2015. Methods All N0-XM0 with ≥T3a, or PCa cases with poorly differentiated feature (equivalent to Gleason score ≥ 8), diagnosed between 2005 and...

Full description

Bibliographic Details
Main Authors: Semaw Ferede Abera, Ahmed Bedir, André Glowka, Dirk Vordermark, Daniel Medenwald
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Cancer
Subjects:
Hormonal therapy
High-risk
Prostate cancer
Treatment
Cancer registry
S3-guideline
Online Access:https://doi.org/10.1186/s12885-022-09677-z

Internet

https://doi.org/10.1186/s12885-022-09677-z

Similar Items